REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

"Trans-Drog" M.Pomaranski,D.Mamrot sp. j. (Poland)

Main Activities: General Freight Trucking
Secondary Activities: Highway, Street, and Bridge Construction | Other Heavy and Civil Engineering Construction | Foundation, Structure, and Building Exterior Contractors | Site Preparation Contractors | Interurban and Rural Bus Transportation | Taxi Service | All Other Nondepository Credit Intermediation
Full name: "Trans-Drog" M.Pomaranski,D.Mamrot sp. j. Profile Updated: April 09, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

"Trans-Drog" M.Pomaranski,D.Mamrot sp. j. is based in Poland. The head office is in Walbrzych. The enterprise currently operates in the General Freight Trucking sector. It was incorporated on February 21, 2006. 101 - 250 (2015) employees currently work for "Trans-Drog" M.Pomaranski,D.Mamrot sp. j.. The company’s latest financial report indicates a net sales revenue drop of 5.02% in 2023. There was a total negative growth of 31.13% in "Trans-Drog" M.Pomaranski,D.Mamrot sp. j.’s total assets over the same period. The net profit margin of "Trans-Drog" M.Pomaranski,D.Mamrot sp. j. decreased by 17.6% in 2023.

Headquarters
Ul. Piotra Czajkowskiego 12
Walbrzych; Dolnoslaskie; Postal Code: 58-300

Contact Details: Purchase the "Trans-Drog" M.Pomaranski,D.Mamrot sp. j. report to view the information.

Website: http://www.trans-drog.pl

Basic Information
Total Employees:
Purchase the "Trans-Drog" M.Pomaranski,D.Mamrot sp. j. report to view the information.
Outstanding Shares:
Purchase the "Trans-Drog" M.Pomaranski,D.Mamrot sp. j. report to view the information.
Incorporation Date:
February 21, 2006
Key Executives
Purchase this report to view the information.
Associate
Purchase this report to view the information.
Associate
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after "Trans-Drog" M.Pomaranski,D.Mamrot sp. j. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-5.02%▼
Total operating revenue
-15.92%▼
Operating profit (EBIT)
-75.19%▼
EBITDA
-57.36%▼
Net Profit (Loss) for the Period
-74.66%▼
Total assets
-31.13%▼
Total equity
-27.17%▼
Operating Profit Margin (ROS)
-18.1%▼
Net Profit Margin
-17.6%▼
Return on Equity (ROE)
-76.81%▼
Quick Ratio
0.24%▲
Cash Ratio
0.15%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo